Deep brain stimulation (DBS) has been used to treat intractable pain for over 50 years. Variations in targets and surgical technique complicate the interpretation of many studies. To better understand its efficacy, we performed a meta-analysis of DBS for pain relief. MEDLINE (1966 to February 2003) and EMBASE (1980 to January 2003) databases were searched using key words deep brain stimulation, sensory thalamus, periventricular gray and pain. Inclusion criteria were based on patient characteristics and protocol clarity. Six studies (between 1977–1997) fitting the criteria were identified. Stimulation sites included the periventricular/periaqueductal grey matter (PVG/PAG), internal capsule (IC), and sensory thalamus (ST). The long-term pain ...
Deep brain stimulation (DBS) is a neurosurgical intervention now established for the treatment of mo...
Object Chronic neuropathic pain is estimated to affect 3–4.5% of the worldwide population, posing a ...
OBJECT: Chronic neuropathic pain is estimated to affect 3-4.5% of the worldwide population, posing a...
Deep brain stimulation (DBS) has been used to treat intractable pain for over 50 years. Variations i...
Deep brain stimulation (DBS) is a neurosurgical intervention whose efficacy, safety, and utility hav...
Deep brain stimulation (DBS) is a neurosurgical intervention whose efficacy, safety, and utility hav...
Objectives:?To determine whether deep brain stimulation is an effective treatment for neuropathic pa...
Objectives. To determine whether deep brain stimulation is an effective treatment for neuropathic p...
As a clinical intervention, deep brain stimulation (DBS) has provided remarkable therapeutic benefit...
Deep brain stimulation (DBS) of the periventricular/periaqueductal gray area and sensory thalamus ca...
UNLABELLED: Deep brain stimulation (DBS) of the periventricular/periaqueductal gray area and sensory...
Chronic neuropathic pain affects 7%-10% of the population. Deep brain stimulation (DBS) has shown va...
The objective of this study is to determine the usefulness of single-patient, randomised, controlled...
Deep brain stimulation (DBS) is a neurosurgical intervention the efficacy, safety, and utility of wh...
Chronic intractable pain is debilitating for those touched, affecting 5% of the population. Deep bra...
Deep brain stimulation (DBS) is a neurosurgical intervention now established for the treatment of mo...
Object Chronic neuropathic pain is estimated to affect 3–4.5% of the worldwide population, posing a ...
OBJECT: Chronic neuropathic pain is estimated to affect 3-4.5% of the worldwide population, posing a...
Deep brain stimulation (DBS) has been used to treat intractable pain for over 50 years. Variations i...
Deep brain stimulation (DBS) is a neurosurgical intervention whose efficacy, safety, and utility hav...
Deep brain stimulation (DBS) is a neurosurgical intervention whose efficacy, safety, and utility hav...
Objectives:?To determine whether deep brain stimulation is an effective treatment for neuropathic pa...
Objectives. To determine whether deep brain stimulation is an effective treatment for neuropathic p...
As a clinical intervention, deep brain stimulation (DBS) has provided remarkable therapeutic benefit...
Deep brain stimulation (DBS) of the periventricular/periaqueductal gray area and sensory thalamus ca...
UNLABELLED: Deep brain stimulation (DBS) of the periventricular/periaqueductal gray area and sensory...
Chronic neuropathic pain affects 7%-10% of the population. Deep brain stimulation (DBS) has shown va...
The objective of this study is to determine the usefulness of single-patient, randomised, controlled...
Deep brain stimulation (DBS) is a neurosurgical intervention the efficacy, safety, and utility of wh...
Chronic intractable pain is debilitating for those touched, affecting 5% of the population. Deep bra...
Deep brain stimulation (DBS) is a neurosurgical intervention now established for the treatment of mo...
Object Chronic neuropathic pain is estimated to affect 3–4.5% of the worldwide population, posing a ...
OBJECT: Chronic neuropathic pain is estimated to affect 3-4.5% of the worldwide population, posing a...